Search clinical trials for: Taxotere , Epirubicin
Total 1191 results
-
University of WashingtonAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
Hebei Medical University Fourth HospitalRecruiting
-
Imperial College LondonCompletedBreast CancerUnited Kingdom, Korea, Republic of
-
Istituto Scientifico Romagnolo per lo Studio e...Unknown
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
Tao ZhangRecruitingGastric Cancer Stage IVChina
-
University of Michigan Rogel Cancer CenterCompletedLaryngeal CancerUnited States
-
George Washington UniversityActive, not recruitingHead and Neck CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Breast... and other collaboratorsTerminatedTriple Negative Breast NeoplasmsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaSanofi; BayerCompletedProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
Active Biotech ABCompletedCarcinoma, Non-Small-Cell LungUnited States, Denmark, Russian Federation
-
Meir Medical CenterCompletedNon-Small Cell Lung CancerIsrael
-
Fudan UniversityCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
Hoffmann-La RocheNorwegian Radium HospitalCompleted
-
Shengjing HospitalNot yet recruiting
-
Institute of Cancer Research, United KingdomActive, not recruiting
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Jonsson Comprehensive Cancer CenterAventis Pharmaceuticals; GenentecCompletedProstate CancerUnited States
-
Francisco Robert,MDSanofi; BayerTerminatedNon Small Cell Lung Cancer | Non Squamous Cell Lung CancerUnited States
-
Cancer Research Group - Collaborative Group, Beirut...Unknown
-
Sun Yat-sen University307 Hospital of PLA; Fudan University; West China Hospital; Tongji Hospital; Second... and other collaboratorsCompletedStomach Neoplasms | ERBB2 Gene Amplification | Neoplasms MetastasisChina
-
Montefiore Medical CenterSanofi; GlaxoSmithKlineCompletedUterine Neoplasms | Ovarian NeoplasmsUnited States
-
University of KansasNovartis; Kansas Masonic Cancer Research InstituteCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; Aventis PharmaceuticalsWithdrawn
-
University of VermontUnknownHead and Neck NeoplasmsUnited States
-
Lyric PharmaceuticalsCompletedEnteral Feeding Intolerance (EFI)United States, Spain, Netherlands
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
SCRI Development Innovations, LLCAventis Pharmaceuticals; Sanofi-SynthelaboCompletedEsophagus CancerUnited States
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
Centre Antoine LacassagneCompletedProstatic NeoplasmsFrance
-
Groupe Oncologie Radiotherapie Tete et CouCompleted
-
University of MiamiTerminatedHead and Neck Cancer | Recurrent Disease | Squamous Cell CarcinomaUnited States
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; BeiGene USA, Inc.; Roche-GenentechRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
The Methodist Hospital Research InstituteMerck Sharp & Dohme LLCSuspendedTriple Negative Breast Cancer | Anthracycline-refractory TNBCUnited States
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
ETOP IBCSG Partners FoundationBiodesix, Inc.CompletedCarcinoma, Non-Small-Cell LungIreland, Switzerland, Denmark, Spain, United Kingdom, Belgium, Hungary, Greece, Israel, Austria, Italy, Netherlands
-
Masonic Cancer Center, University of MinnesotaSanofiCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Nerium BiotechnologyWithdrawnLung Cancer | Chemotherapeutic Agent Toxicity
-
Stanford UniversityAventis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell Lung | Lung CancerUnited States
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
Groupe Français de Pneumo-CancérologieSanofi; Chugai Pharma USACompletedNon Small Cell Lung CancerFrance
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerCanada
-
Fudan UniversityUnknown
-
Stanford UniversityCompletedHead and Neck CancerUnited States